IRIS International, Inc. (NASDAQ: IRIS) announced the acquisition of Leucadia Technologies, Inc., a molecular diagnostics company, for $10.1 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE